Norbert Bräu

8.6k citations
88 papers · 6.9k · 5 hit papers · h-index 30

Impact in

  • Hepatology top 0.1%
    • Hepatitis C virus research
    • Liver Disease and Transplantation
  • Epidemiology top 0.5%
    • Liver Disease Diagnosis and Treatment
    • Hepatitis B Virus Studies

Papers in

    • Hepatitis C virus research 61
    • Hepatocellular Carcinoma Treatment and Prognosis 4
    • Liver Disease Diagnosis and Treatment 17
    • Hepatitis B Virus Studies 10

Norbert Bräu

86 papers receiving 6.6k citations

Norbert Bräu's Hit Papers

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia 2021 · 755 citations
7550+4+8Years since publication4008001.2k

Peers

Norbert Bräu
Comparison fields: 5 of 119
  • Hepatology 5.1k
  • Epidemiology 3.0k
  • Infectious Diseases 1.4k
  • Transplantation 86
  • Virology 132
Replace Susanna Naggie with:
Susanna Naggie United States
Javier García‐Samaniego Spain
Nina M Weis Denmark
David L. Wyles United States
Kristen Marks United States
David Mutimer United Kingdom
Robert P. Perrillo United States
Stefan Mauss Germany
Caterina Sagnelli Italy
Luz Martín‐Carbonero Spain
Norbert Bräu relative to Susanna Naggie United States Susanna Naggie's profile →
Citations per field
00.5×2×2.6×
Susanna Naggie · 1×
Citations per year

Countries citing papers authored by Norbert Bräu

Since Specialization
Citations

This map shows the geographic impact of Norbert Bräu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norbert Bräu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norbert Bräu more than expected).

Fields of papers citing papers by Norbert Bräu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norbert Bräu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norbert Bräu. The network helps show where Norbert Bräu may publish in the future.

Co-authors

The 25 scholars most cited alongside Norbert Bräu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Norbert Bräu Line = papers co-authored together Norbert Bräu links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 88 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Hit paper breakdown →
20141457
2
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Hit paper breakdown →
2021755
3
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Hit paper breakdown →
2015697
4
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Hit paper breakdown →
2015386
5
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
Hit paper breakdown →
2017317
6 2005293
7 2007275
8 2007201
9 2017188
10 2003177
11 2005138
12 2012130
13 2017125
14 2005111
15 2014108
16 1997103
17 201598
18 200696
19 200465
20 200563

About Norbert Bräu

Norbert Bräu is a scholar working on Hepatology, Epidemiology, Infectious Diseases, Hematology and Rheumatology, having authored 88 papers that have together received 6.9k indexed citations. Recurring topics across this work include Hepatitis C virus research (61 papers), Liver Disease Diagnosis and Treatment (17 papers), HIV/AIDS drug development and treatment (11 papers), Hepatitis B Virus Studies (10 papers), Systemic Lupus Erythematosus Research (5 papers), Blood groups and transfusion (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Viral-associated cancers and disorders (3 papers). The work is most often cited by research in Hepatology (5.1k citations), Epidemiology (3.0k citations), Infectious Diseases (1.4k citations), Transplantation (86 citations) and Virology (132 citations). Norbert Bräu has collaborated with scholars based in United States, United Kingdom and Italy. Frequent co-authors include Mark Sulkowski, Maribel Rodriguez‐Torres, Edmund J. Bini, Douglas T. Dieterich, Fiorenzo Paronetto, Carlos F. Ríos‐Bedoya, José F. Rodríguez‐Orengo, Stanislas Pol, Mirella Salvatore and Tarek Hassanein. Their work appears in journals such as Journal of Hepatology, Clinical Infectious Diseases, The American Journal of Gastroenterology, New England Journal of Medicine and Journal of Viral Hepatitis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact